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Abstract
Background: Glaucoma is a progressive eye disease and a leading cause of visual disability. Automated assessment of the
visual field determines the different stages in the disease process: it would be desirable to link these measurements taken in
the clinic with patient’s actual function, or establish if patients compensate for their restricted field of view when performing
everyday tasks. Hence, this study investigated eye movements in glaucomatous patients when viewing driving scenes in a
hazard perception test (HPT).
Methodology/Principal Findings: The HPT is a component of the UK driving licence test consisting of a series of short film
clips of various traffic scenes viewed from the driver’s perspective each containing hazardous situations that require the
camera car to change direction or slow down. Data from nine glaucomatous patients with binocular visual field defects and
ten age-matched control subjects were considered (all experienced drivers). Each subject viewed 26 different films with eye
movements simultaneously monitored by an eye tracker. Computer software was purpose written to pre-process the data,
co-register it to the film clips and to quantify eye movements and point-of-regard (using a dynamic bivariate contour ellipse
analysis). On average, and across all HPT films, patients exhibited different eye movement characteristics to controls making,
for example, significantly more saccades (P,0.001; 95% confidence interval for mean increase: 9.2 to 22.4%). Whilst the
average region of ‘point-of-regard’ of the patients did not differ significantly from the controls, there were revealing cases
where patients failed to see a hazard in relation to their binocular visual field defect.
Conclusions/Significance: Characteristics of eye movement patterns in patients with bilateral glaucoma can differ
significantly from age-matched controls when viewing a traffic scene. Further studies of eye movements made by
glaucomatous patients could provide useful information about the definition of the visual field component required for
fitness to drive.
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Introduction
Glaucoma is a chronic progressive neuropathy involving the
visual pathway: it is the most common cause of irreversible
blindness in the world and a leading cause of visual morbidity.
Given its chronic progressive nature, the rise in prevalence with
age and the increasing longevity of the population, the impact of
the disease is substantial and rising.
Automated visual field assessment is the principal functional
measurement in the clinical management of patients with
glaucoma. However, insight into how visual field defects
manifesting at different stages in the disease process impact on
patients’ everyday visual function is only recently gaining
momentum in the research literature. Linking the clinical
measurements to what patients can do functionally is important
in the management of the condition. For example, there is
emerging evidence of glaucomatous patients being at greater risk
of falls and accidents, even with relatively modest visual field
defects [1,2,3]. There is also evidence of the impact of
glaucomatous field defects on self-reported disability [4,5,6,7,8]
and, more recently, objective measures in laboratory based studies
demonstrate the difficulty patients have with some everyday tasks
[9,10]. Glaucoma undoubtedly impacts on an individual when
visual field loss causes the removal of a driving licence, and several
studies of varying experimental design have shown that certain
glaucomatous visual field defects are not compatible with safe
driving [1,11,12,13]. The issue of driving with glaucoma is a
serious one, with a significant proportion of patients suffering
visual loss that results in driving ineligibility, certainly in the UK
[14,15]. Moreover, it has been demonstrated that patients perceive
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them as the long-term risk of blindness [16].
One aspect of visual function in glaucoma that has received little
attention is eye movements. It is accepted that patients’ perception
of the severity of their peripheral visual field loss is influenced by
one eye essentially ‘filling in’ for the other, but very little is known
about how eye movements might contribute to any compensatory
mechanism for loss of function. It would, for example, be useful to
know if glaucoma patients exhibit the same eye movement
behaviour as healthy subjects, or maintain the same point of
regard when looking at, or interpreting, an everyday scene. This
evidence may inform future studies that attempt to relate the
severity, extent and location of a visual field defect to what a
patient can and cannot do in terms of real life activities, especially
driving. It may even provide a basis for incorporating attention to
eye movements into visual rehabilitation and coping strategies for
the patient with glaucoma.
The Hazard Perception Test (HPT) was introduced as an
element of the UK driving licence theory test in 2003 as a measure
to encourage appropriate visual scanning of the road or highway
and to develop the ability to recognise at the earliest opportunity
that a potentially dangerous driving situation might arise. In this
context a ‘learner driver’ is shown a film of a real driving scene,
seen from the perspective of the driver, with the task being to
detect potential ‘hazards’: these are defined as something that
would make the camera car take evasive action, such as braking
for an oncoming cyclist or a pedestrian unexpectedly crossing the
road/street. Primarily, it is a useful educational tool allowing
learner drivers to encounter ‘on road’ driving scenes from the
safety of a computer monitor. A subject’s performance on the
HPT is clearly dependent on instruction, prior experience and
perception of what represents a driving hazard, and HPT
performance in terms of simply detecting a hazard in visually
healthy subjects is certainly variable [17]. Previously the HPT, as a
simple reaction test to hazards, was investigated as a potential
proxy measure for identifying visual defects that would impinge on
fitness to drive, and was found to have limited value for this
purpose [18]. Whether the HPT is an indicator of subjects’ visual
strategies when driving under the conditions in which they are
most likely to have an accident is open to debate, and is not the
subject of this study. Rather, for the purposes of this study, this
realistic and relevant visual scenario can be ‘played out’ on a
computer screen allowing for accurate gaze tracking in a
controlled laboratory setting, thus making it most suitable for
examining the eye movement behaviour of glaucomatous patients
compared to control subjects whilst viewing an everyday scene.
The aim of this study is to perform eye tracking on subjects as
they simultaneously view a series of HPT film clips to examine the
hypothesis that patients with binocular glaucomatous field defects
exhibit significant differences in eye movement characteristics to
healthy control subjects. Moreover, in the context of visual field
defects and fitness to drive, the data can also be used to examine
qualitatively how these patients’ eye movements relate to the
events and hazards in the video sequences.
Materials and Methods
Ethics Statement
The study was approved by the ethics committee of each of the
participating institutions where subjects were recruited (Moorfields
and Whittington Research Ethics Committee, London; School of
Community and Health Sciences Research and Ethics Commit-
tee, City University London). All participants were asked about
their general health and were excluded if they were on any
significant medication (other than that for their glaucoma).
Written informed consent, according to the tenets of the
Declaration of Helsinki, was obtained prior to examination from
each subject. All the data, with patient identifiers removed, were
transferred to a secure computer at the university.
Subjects
This study took advantage of some of the data collected as part
of a UK Department for Transport (DfT) funded study conducted
at City University London, fully reported elsewhere [17,18]. In
short, this UK DfT study aimed to examine the agreement
between the outcome of conventional visual field tests and proxy
measures of driving safety in subjects with binocular paracentral
scotoma, resulting from a range of visual disorders, but preserved
visual acuity (VA). One experiment in the original study, not
performed on all study participants, examined the performance of
subjects on the HPT whilst eye movements were simultaneously
recorded. Glaucoma patients were recruited from the Central
Middlesex Hospital (North West London Hospitals NHS Trust),
Moorfields Eye Hospital Trust London and the Fight for Sight
Optometry Clinic at City University London. Data from these
patients, along with those from a group of visually healthy control
subjects, are the subject of this study.
All patients had a clinical diagnosis of glaucomatous optic
neuropathy (primary open angle glaucoma) in both eyes and are,
therefore, representative of those patients who should undergo
further testing to satisfy the visual field requirements for legal
fitness to drive in the UK [17,19]. Prior to inclusion in the study,
all patients had a full eye examination including central visual
fields (24-2 or 30-2 SITA Standard) recorded on a Humphrey
Visual Field Analyzer (HFA, Carl Zeiss Meditec, CA, USA).
Patients were excluded if they produced unreliable fields at this
first visit. VA of at least 6/9 was required in both eyes, with no
other significant ocular disease reported other than glaucoma.
Visually healthy control subjects were recruited from University
staff, centres for the elderly and the University optometry clinic. A
full eye examination, including HFA visual fields, was carried out
to exclude any abnormality before a volunteer was accepted into
the study. A VA of at least 6/9 was required for each eye.
The HPT film clips used in this study have been used elsewhere
[20] and consisted of 26 short films (range 40–73 seconds) showing
a range of driving environments (e.g. dual-carriageway or divided
highway, rural lane, busy urban streets). Each film contained
between one and three ‘hazardous driving events’. The films were
digitised (with a standard mpeg codec running at 25 frames per
second) and shown on a 42 inch plasma widescreen monitor (1280
by 1024 pixel resolution) in a rectangle of width 824 mm and
height 512 mm. Participants were seated at a chin rest 120 cm
from the screen and the image subtended 39u horizontally and 25u
vertically. Eye movements were monitored using a SMI Eyelink
eye tracker (SensoMotoric Instruments, Teltow, Berlin, Germany)
sampling at 250 Hz. The SMI eye tracker has reported spatial
accuracy better than 0.5u. Calibration, drift correction, and
validation were performed using the algorithms provided by the
instrument. In this system, adjustment of the measurements for
head position is carried out automatically using detectors in the
four corners of the monitor, but a chin rest was also used to
stabilise head movements and ensure a constant viewing distance.
Participants were all given the same verbal instructions: that
they should look out for events that would cause the camera-car to
take evasive action such as braking or evasive steering. They held a
response button in their preferred hand, and were instructed to
press the button whenever they judged one of these hazards as
imminent. This ‘press button’ performance in the actual hazard
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analysis indicated large variability in ‘press button’ scores and the
influence of subject specific definition of what constitutes a hazard
[18]. Following calibration of the eye tracker, each subject was
shown two introductory films prior to the commencement of data
collection, to allow them to familiarise themselves with the task.
The film clips were presented in random order with occasional rest
periods between films.
Participants were asked to estimate the number of years they
had been actively driving. For this study, participants were
excluded if they had never held a valid driving licence or had less
than 5 years driving experience. Moreover, for this study analysis
was restricted to participants that were 50 years of older at the
time of the study to ensure that the mean and distribution of age
was matched between participants with glaucoma and controls.
None of the participants had previously performed the HPT and
were therefore naı ¨ve to the task.
Analysis
The eye tracker yields an enormous amount of raw data:
essentially a trace of ‘gaze’ recorded as (x,y) coordinates related to
the viewing area every 4.2ms for each film. The results from this
experiment contained more than six million of these data points. A
bespoke application written in Microsoft Visual C# was developed
for analysing these time series [21] and this is freely available from
the authors; what follows is a short description of the techniques
employed in the main analysis.
Eye movements were divided into fixations, saccades and
‘smooth pursuits’ using a velocity based criterion. One difficulty is
correctly separating these movements from the variability in the
measurement process. Therefore, a noise removal technique was
first applied to the data which filters out highly variable non-
physiological measurements (high frequency noise) by taking a
window or block of 50 (x,y) coordinate eye gaze positions (around
210ms) and calculates the speed of any eye movement between the
positions recorded at time point t and t+1. If more than 75% of the
recordings within that window move at 30u/s or more then the
whole window is removed from the trace because these
measurements are assumed less likely to be physiological
movements and are more likely attributed to measurement
variability. The window moves along the trace to perform the
same procedure on the next 50 samples. On completion, an eight
sample median filter is passed over the remaining data to remove
or dampen ‘low frequency’ noise. Blinks (denoted by zero value
data), gaze outside the viewing area and other eye tracking failures
were identified then removed from the traces. Films in which less
than 40% of the recordings remained were discarded to ensure
that we were not removing too much data per film, following a
previously used protocol [22].
Once the data are filtered, saccades were defined as the
proportion of the trace where the velocity of the eye movement is
faster than 30u/s. This criterion of 30u/s or higher for identifying
saccades is common in eye movement studies and eye tracking
instrumentation, since this is considered the upper limit of pursuit
eye movement speed.[23,24,25] Any saccade exceeding a duration
of 120 ms or is less than 10 ms were excluded from the analysis. In
addition saccades that originate or terminate outside the confines
of the dimensions of the display of the film (calibration errors) were
excluded from the analysis. Fixations were defined as the
proportion of the trace where gaze was ‘still’ and the velocity of
the eye movement is less than 1.5u/s. We defined periods of the
trace where the speed was greater that 1.5u/s but less that 30u/s to
be ‘pursuit’ movements, where gaze was most likely ‘tracking’ a
moving object in the film. In truth, these pursuit movements are
very difficult to quantify even with a sophisticated eye tracker
operating at a high frame rate, but we shall refer to them as
possible ‘smooth pursuits’ lacking the stability characteristic of a
fixation, but without being fast enough to be classified as a
physiological saccade. The algorithm then automatically records
the number of fixations, the number of saccades and the number
of smooth pursuits per second of film. It also yields average fixation
duration (ms), average ‘smooth pursuit’ duration (ms) and average
saccade amplitude (size in degrees). These six summary eye
movement parameters were recorded for each film as viewed by
each subject.
The experimental design aimed to minimize ‘the between
subject measurement variability’ in the eye movement parameters
with all participants viewing the same films, so these were assumed
to be the blocks in the experiment. A General Linear Model
(GLM) was used to perform univariate analysis of variance
(ANOVA) with an unbalanced design (accommodating missing
data by the method of median imputation) to assess each of six
different eye movement parameters (response variables) using the
statistical software package Minitab v.14 (Minitab Inc., Pennsyl-
vania, USA). In this two way ANOVA arrangement, variation in
the response variable (each eye movement parameter) was
expected to be different across the films and across the subjects,
with the null hypothesis of real interest being no difference in the
average value for the eye movement parameters between the
patients and controls examined (F test on the main factor,
participant group, from the ANOVA).
In order to consider the hypothesis that any differences in eye
movement characteristics between patients and controls were
similar at the time of the hazards compared to sequences of the
HPT where no hazards occurred, the films were divided into ‘safe’
and ‘unsafe’ segments. One of the authors (NS) carefully reviewed
all the films and identified the sequence in the film where the
hazard emerged and then ended. The six summary eye movement
parameters were calculated for both the ‘hazard sequence’ and the
‘non-hazard’ sequence for each film and each participant. The
individual differences were then calculated, and these differences
were treated as the response variable analysed with a GLM
ANOVA. The null hypothesis being no difference in the average
value for the eye movement parameters between the patients and
controls examined in the two different sequences (F test on the
main factor, participant group, from the ANOVA).
A novel ‘point of regard’ analysis was also implemented. The
eye tracking sequence is co-registered to the film sequence with
each frame of the film equating to nine eye-tracking samples; a
mean of these (x,y) points is defined as the ‘point of regard’ for that
frame. This is repeated for all the control subjects such that each
film frame has a sample of ‘points of regard’ (x,y), one for each
control subject, for that particular frame. To quantify the spatial
coincidence of the point of regard location for all the control
subjects, we calculated the best-fit bivariate contour ellipse (BCE).
The BCE area has been previously used to quantify fixation eye
movement stability in patients with macular degeneration
[22,26,27] and to quantify viewing areas for subjects as they
watch movies [28]. For our application we implemented the
method as described by Goldstein et al [28] but in a novel
development we also plotted the ellipse on each frame of the film
[29,30] thus giving a dynamic visual representation of the region
of interest for the control subjects. The centre of the BCE
represents the mean ‘point of regard’ of the controls, with the
spatial extent of the ellipse being one standard deviation from this
centre along two principal axes, theoretically affording ‘coverage’
of approximately 67% of the ‘point of regard’ locations in a given
frame. The percentage of patients’ points of regard falling inside
Eye Movements in Glaucoma
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glaucomatous patients were, on average, viewing the same parts of
the driving scene as the visually healthy subjects.
Monocular visual fields for the patients were merged to form an
integrated visual field [19,31]: a simulated binocular visual field in
which patients’ best point-by-point monocular sensitivity is used
(PROGRESSOR software: Moorfields Eye Hospital, London,
UK/Medisoft Ltd., Leeds, UK). The software application
developed in this work then aligns and scales a greyscale of this
binocular field of view to the gaze point for each patient; this
provides a dynamic illustration of a patient’s restricted field of view
as the film sequence runs, giving an insight into the difficulty of the
task from the patient’s perspective.
Results
Data from nine glaucomatous patients and ten age-matched
healthy control subjects fulfilled the inclusion criteria used for this
study. The mean age of the patients was 67.6 (SD:9.3) years
compared to a mean age of 64.4 (SD=11.4) years for the control
subjects (Averages not significantly different; P=0.52; two sample
t-test. Variances not significantly different; P=0.59; F-test). The
self-reported mean number of years actively driving was 29
(SD=10) and 30 (SD=12) for the patients and the controls
respectively (averages not significantly different; P=0.86; two
sample t-test). The patients had a range of visual field defect
severity: average HFA mean defect (MD) was -8.0 (SD=8.8) dB,
-5.4 (SD=5.7) dB and -8.9 (SD=8.6) in the right eye, left eye and
worse eye, respectively.
A small number of films were missing for the nine patients and
ten control subjects because of corrupt data or particularly noisy
sequences where more than 60% of the data were removed by the
filtering: a threshold used in previous studies.[22] This affected
results from one control subject and two glaucomatous patients,
but none of these had fewer than 23 films available for analysis.
Prior to settling on the numbers for this study, other subjects
fulfilling all the other inclusion criteria for the study (2 patients and
2 controls) had several films (more than 12) where a large
proportion of data were corrupt, missing, poorly calibrated or had
more that 60% removed by the filtering algorithm: these subjects
(some of whom had reported difficulty with the task or eye tracking
failures) were not included in the final 19 assessed.
Each of the eye movement parameters was assessed in a GLM
ANOVA: the departure of the F statistic (on 1 and 25 degrees of
freedom) from 1 summarises the extent of a difference in the main
factor (patients versus controls) and the P-value refers to the null
hypothesis of no effect, or no difference, in that main factor. (No
obvious departure from Normality was observed in any of the
response variables as assessed by the Kolmogorov-Smirnov test).
There was considerable statistical evidence that on average
patients made more saccades per second (P,0.001; F1,25=48.6;
mean increase 15.8%; 95% confidence interval [CI]: 9.2 to
22.4%), more fixations per second (P,0.001; F1,25=53.4; mean
increase 16.9%; 95% CI: 11.7 to 22.1%) and more smooth
pursuits per second (P,0.001; F1,25=85.3; mean increase 18.4%;
95% CI: 14.4 to 22.4%) than the control subjects. There was no
evidence for a difference in average saccade amplitude (P=0.12;
F1,25=2.6) There was evidence of average duration of the fixations
being shorter in patients (P,0.001; F1,25=29.6; mean difference
16.5%; 95% CI: 10.0 to 23.0%) compared to controls. There was
also evidence of the average duration of smooth pursuits being
significantly greater in the controls compared to the patients
(P,0.001; F1,25=22.1; mean difference of 7.4%; 95% CI 3.2 to
11.6%). These results are further illustrated in figure 1: each graph
considers a different eye movement parameter, with each point in
the graph being the result from each of the 26 films. If the average
value for an eye movement parameter for the patients was
identical to the controls’ then the point would fall exactly on the
line of unity. The relative position of the points either below or
above this line of unity gives a graphical indication of the
magnitude and direction of the experimental effect and illustrates
the ANOVA results.
Ten of the films had one hazard, fourteen films had two hazards
and two films had three hazards. On average, and across all films,
the ‘hazardous’ sections made up 18% (95% CI: 15 to 21%) of the
total film sequence. The difference in each of the six eye movement
parameters, for each film and for each subject was calculated then
used as the response variable in a GLM ANOVA. As before, the F-
statistic on the main factor (patients versus controls) was assessed,
with the null hypothesis that there was, on average, no effect across
the patients and controls between hazard and non-hazard
sequences. There was no such significant effect in any of the eye
movements across the main factor (F1,25 less than 2.92 and P at least
.0.10 in all 6 parameters). For example, the average percentage
increase in number of saccades per second for the patients
compared to controls was 15.7% during the non-hazard sequence
(95% CI: 8.9 to 22.5) and 16.3% (95% CI: 6.2 to 26.4 %) during the
hazard sequence. This does not support a hypothesis that
differences in eye movement measurements between glaucomatous
patients and control subjects became more significant or more
exaggerated during the ‘hazardous’ parts of the film.
The BCE analysis attempted to compare the overall viewing
region of the two groups (figure 2 and Audio/Video - S1). The
mean number of points of regard that fell in the BCE was
calculated for each patient with the overall average for the
glaucomatous group being 62.8% (SD 8.3%). This average was
clearly not significantly different from the theoretically expected
value (67%) generated from the control group (P=0.49; one
sample t-test). In some films, this average value was as high as
84.9% and in others as low as 56.1% but there did not seem to be
any observed pattern of viewing region in the patients departing
from that of the controls being associated with the type of driving
scene (e.g. rural, urban, divided highway/dual carriageway). In
short, participants tended to view the same overall region of the
driving scene whether they were glaucomatous or not, but this was
on average, and considering the group as a whole. By using the
software developed for this study it was possible to follow the
viewing pattern of individual patients as they viewed the different
films and compare this view with the pattern from all the control
subjects simultaneously. Although difficult to quantify, there were
some very revealing examples of individual patients clearly not
following the control viewing pattern and unambiguous cases
where the patient was unaware of emerging hazards. These
examples became more informative when the integrated visual
field defect of the patient was superimposed on the films giving a
perspective of the patient’s ‘struggle’ with their restrictive
binocular central field defect. One of these cases is shown as a
montage in figures 3 and as film clips in Audio/Video - S2,
Audio/Video - S3.
Discussion
These results provide some new evidence that some character-
istics of eye movements in glaucomatous patients with binocular
visual field defects are different to those of healthy control subjects
when performing the HPT. On average, the patients made more
saccades and more fixations than controls. With this task we
speculate that patients are, unconsciously or otherwise, making
Eye Movements in Glaucoma
PLoS ONE | www.plosone.org 4 March 2010 | Volume 5 | Issue 3 | e9710Figure 1. Eye movements for patients and controls. Graphs showing the average response in each eye movement parameter for the patients
and the controls with (a) average number of saccades per second; (b) average number fixations per second; (c) number of smooth pursuits per
second of film; (d) average saccade amplitude (size in degrees); (e) average fixation duration (ms); and (f) average ‘smooth pursuit’ duration (ms). Each
symbol represents the results from one of the 26 films. If there were no differences in the averages then symbols would fall exactly on the line of
unity. For example, (a) indicates that the patients made, on average, more saccades across the films than the control subjects, which illustrates the
statistically significant effect found in the GLM ANOVA.
doi:10.1371/journal.pone.0009710.g001
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restricted field of view. Since a binocular visual field defect reduces
the amount of visual information available, this might suggest
fewer eye movements [32], but this was not the case when patients
were viewing these moving images. Our results also indicate that
fixation duration was, on average, shorter with patients compared
to controls. In contrast, it has been previously shown that fixation
duration increases with the size of absolute central scotomas, but
this was in a study using artificial scotomas on healthy subjects and
a different task (searching a static image) [32]. Others have shown
a reduction in fixation duration when an artificial scotoma is used
to block foveal vision. [33]
Whilst most of the eye movement measurements were, on
average, different between patients and controls, the BCE analysis
indicated that patients were, on average, looking at the same areas
as control subjects in the HPT movies. Despite the novelty and
computational difficulty of this analysis it is probably too
insensitive to the subtle departures in patient gaze as compared
to the controls. The BCE area was often relatively large, being
poorly estimated with so few controls. Moreover, there was no
evidence from this sample to support the idea that eye movements
become more or less exaggerated in patients compared to controls
during the sequence of the film where a hazard was present or
emerging. This temporal analysis suffers from the difficulty of the
likely weaker estimates of the eye movement measurements during
the hazard sequence because they only make up a smaller
percentage of the film sequence. Looking at individual cases
viewing individual films is helpful but provides little quantitative
information about how the patients differ from a ‘normal’ viewer.
A better post-hoc analysis might mark out areas in the frames that
are of interest, perhaps associated with the looming hazards, and
then quantify the patient’s gaze falling in these areas. Such an
analysis would need larger sample numbers than made available
for this study to provide an adequate comparison.
Eye movement studies in ‘real world’ or simulated ‘real world’
environments have tended to focus on experiments with artificial
scotomas or, when carried out in patient groups, with retinitis
pigmentosa (RP) [34,35] and age-related macular degeneration
(MD) [36]. Few studies have previously examined eye movement
behaviour in glaucomatous subjects. An elegant study by Cheong
et al [37] examined ‘traffic gap’ judgement and eye movements in
subjects with peripheral visual field loss, including three subjects
with glaucoma, as compared to healthy subjects. They reported
restricted gaze patterns using the BCE approach but little evidence
of difference in saccade amplitudes, or fixation duration. Eye
tracking experiments by Geruschat et al [38] demonstrated that on
Figure 2. Novel ‘Point of Regard’ Analysis. Examples of the BCE ‘point of regard’ analysis superimposed on frames from some of the HPT films.
The centre of the red ellipse represents the mean ‘point of regard’ of the controls with the spatial extent of the ellipse being one standard deviation
from this centre along two principal axes, theoretically affording ‘coverage’ of approximately 67% of the ‘point of regard’ locations in a given frame.
Note how the location and spatial extent of this ellipse changes with each frame of the film as the control subjects’ view is drawn to different aspects
of the changing road scene. For each frame the number of patients’ points of regard (blue symbols) ‘captured’ by the ellipse can be automatically
counted and compared to the expected value under the null hypothesis that the average ‘viewing area’ is the same in the two groups. Note that not
all nine patients are recorded in each frame because of blinks, loss of data, and variable responses. Also, note that in the UK vehicles are driven on the
left hand side of the road. See Audio/Video - S1.
doi:10.1371/journal.pone.0009710.g002
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visual fields for one of the participants with bilateral glaucoma. The integrated visual field is scaled and superimposed on the point of regard HPT film
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patterns as compared to controls when crossing a street.
Coeckelbergh et al [39] measured eye movements on a simple
static search task and attempted to relate these to an actual on-
road driving test in 50 subjects with field loss, some of whom were
glaucomatous (number not given in the study). The number of
fixations in the search task increased as a function of the size of the
peripheral visual field defect, a finding consistent with our results.
They reported some association between fixation duration and
severity of central field defect but then indicated that eye
movement parameters recorded during a simple static search task
did not predict viewing behaviour in the actual task of driving.
This is not surprising since gaze patterns are intrinsically related to
the specific task: their patterns obtained from a static search task
are likely to differ from patterns for a ‘driving’ task. Indeed eye
movement patterns for the latter have been shown to be extremely
complex [40].
The HPT was previously studied as a possible surrogate for the
UK visual field standard for fitness to drive [18]. The main
measurement considered was the press button response which
yielded the percentage of hazards missed and the mean hazard
response time. The main finding from this study was that the
HPT, when using detection and speed of detection of the hazard,
was of limited value when used alone in identifying subjects with
visual field loss incompatible with current UK driving standards.
Our current interest in the HPT is quite different: for the purpose
of our current study, the HPT is used as a realistic, dynamic,
visually challenging ‘scene’ whilst eye movements are simulta-
neously recorded.
As in any case-control study it is prudent to highlight potential
confounders. The patients were age-matched to the controls and
previous work with the HPT and eye movement analysis in
healthy subjects has shown there is little evidence of an age-related
difference in HPT performance anyway [41]. It has been
previously shown that experienced drivers demonstrate more
extensive scanning than the novices in performing the HPT
[42,43]. In this study we only included participants that had driven
for at least 5 years, and the patient and control groups were almost
identically matched for self reported years of driving experience.
Participants were excluded from the original study if they were on
any ‘significant medication’ other than that for their glaucoma.
Significant medication’ included anti-depressants or treatment for
diabetes or significant use of b-blocker medication, all of which
were deliberately mentioned. However, this was done by self
report rather than verification with their general medical
practitioner and this might limit the interpretation of the results.
Moreover, participants may not have reported use of mild anti-
hypertensive or statins or other commonly used drugs in an elderly
population. There is, however, no reason to suspect that the
glaucomatous group would have had more or less of these
participants compared to the age-matched control group.
Other caveats to be considered when interpreting the results
from this study include the difficulty in truly identifying and
separating the different types of eye movement, especially
delineating saccades from smooth pursuits when the participant
observes a moving image. This is a challenging task even with
modern eye tracking instrumentation. We took the approach of
excluding some subjects and removing significant sections of eye
movement traces where it was not possible to identify clearly the
different movements using an algorithm based on eye movement
velocity developed for the purpose. The experiment was not an
easy one for some subjects to perform, taking around 30 minutes
to view all the film clips, and this probably contributed to the
variability in the measurements. Furthermore, the patient group
for our study was small, meaning population inference should be
treated cautiously, but the sample size was certainly equivalent to
those used in many experimental eye movement studies in the
literature.
Anecdotally, some patients criticize the current static binocular
visual field test (Esterman Test) used to establish legal fitness to
drive in the UK for not allowing ‘scanning’ for a target. An eye
movement and HPT task might be useful as a test for visual field
restriction and fitness to drive. The set up would benefit from
films shown on a larger screen, equivalent to that ‘view’ from a
vehicle, and an eye tracker device that allows for natural
movements. Such a test would not be reliant on press-button
defined hazard detection but could simply monitor the patient’s
natural gaze. A post-hoc analysis of gaze patterns, compared to
visually healthy control subjects, as illustrated in this study, could
determine if patients ‘saw’ hazards, road/traffic signs and events
that might provide evidence for them being visually ‘safe’ drivers.
Taken alone it is very unlikely that such an idea would solve the
difficulty of determining the vision standard for fitness to drive,
the skills for which are so multifactorial that it defies one simple
standard. Besides, the low task demand of watching a film may
give an impression of competent driving performance that may
not be maintained if someone is controlling a vehicle.
Nevertheless, given the debate about current visual field
standards for driving [44,45] such an approach may warrant
further investigation.
The films showing, frame by frame, a patient’s gaze pattern
diverging from those of a number of visually healthy subjects
provide a revealing insight into the visual impairment caused by
glaucoma. This is particularly striking when the individual
binocular visual field defects, made dynamic by aligning them to
the moving point of regard, are superimposed on the films. One
significant output from this work has been the use of these films in
educational/awareness programmes for glaucoma in the UK and
the subsequent interest they have generated, including a feature on
the BBC (British Broadcasting Corporation) News [46].
In conclusion, this exploratory study provides some new
evidence that patients with bilateral glaucoma exhibit different
eye movement behaviour compared to visually healthy subjects
when viewing a driving scene. We hope these results from this
exploratory study will at least stimulate investigations into the
novel idea that eye movement studies, perhaps coupled with work
on patient’s adaption to visual field defects, might provide a new
‘window’ into understanding the functional deficits of glaucoma.
We speculate that understanding such ‘real world’ visual function
deficits in glaucoma is perhaps a first step towards designing
appropriate strategies for patient education about the impact of a
visual field defect and potential rehabilitation, an overlooked area
to give a representation of the restricted field of view. The panels show a montage of selected frames from one of the films. In the top frame, whilst
most of visually healthy subjects (red symbols) fixate on the pedestrian with a pram/pushchair, seeing them as a potential hazard, the patient (blue
symbol) fails to alter their gaze. Similarly in the next frames most of control subjects quickly move their fixation towards the looming hazard of the car
hazardously turning on to the main street from the right intersection. Note that in the UK vehicles are driven on the left side of the road. The patient’s
view of this hazard is masked by their defect and they do not alter their gaze even at the late stage where the camera car ‘brakes’ to take evasive
action (bottom frame). This patient has a binocular visual field that is on the borderline of satisfying the UK guideline for visual field fitness to drive.
This montage is shown as a film in Audio/Video - S2 and Audio/Video - S3.
doi:10.1371/journal.pone.0009710.g003
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Further studies in eye movements and glaucoma are already
underway in our laboratory.
Supporting Information
Audio/Video S1 Novel ‘Point of Regard’ Analysis film. Video
example of the BCE ‘point of regard’ analysis superimposed on a
HPT film from figure 2. The centre of the red ellipse represents
the mean ‘point of regard’ of the controls with the spatial extent of
the ellipse being one standard deviation from this centre along two
principal axes, theoretically affording ‘coverage’ of approximately
67% of the ‘point of regard’ locations in a given frame.
Found at: doi:10.1371/journal.pone.0009710.s001 (9.16 MB AVI)
Audio/Video S2 Participants ‘point of regard’ during HPT film.
Video of the HPT film from figure 3 showing the ‘point of regard’
of all the control subjects. The blue point represents the point of
regard for a glaucomatous patient Note that in the UK vehicles are
driven on the left hand side of the road.
Found at: doi:10.1371/journal.pone.0009710.s002 (7.17 MB AVI)
Audio/Video S3 Participants ‘point of regard’ during HPT film
showing a patient’s ‘view’. Video of the HPT film from figure 3
showing the ‘point of regard’ of the glaucomatous patient in video
S2 with their binocular integrated visual field superimposed. The
degree of transparency relates to the patients defect in that region,
with the least transparent regions being most defective. Note that
in the UK vehicles are driven on the left hand side of the road.
Found at: doi:10.1371/journal.pone.0009710.s003 (7.48 MB AVI)
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